Previous 10 | Next 10 |
The following slide deck was published by Omnicell, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Omnicell, Inc. (OMCL) Q3 2019 Earnings Conference Call October 24, 2019, 16:30 ET Company Participants Peter Kuipers - EVP & CFO Randall Lipps - Founder, Executive Chairman, President & CEO Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Group Mic...
Omnicell (NASDAQ: OMCL ): Q3 Non-GAAP EPS of $0.76 beats by $0.05 ; GAAP EPS of $0.46 beats by $0.03 . Revenue of $228.8M (+12.0% Y/Y) misses by $3.06M . Press Release More news on: Omnicell, Inc., Earnings news and commentary, Tech stocks news,
Record GAAP and non-GAAP revenues of $228.8 million, up 12.0% year-over-year GAAP net income per diluted share of $0.46, up 39.4% year-over-year Record non-GAAP net income per diluted share of $0.76, up 20.6% year-over-year Omnicell, Inc. (NASDAQ: OMCL), a leading provider of...
Kentucky-based Med Center Health Will Upgrade to Omnicell XT Automated Dispensing Cabinets to Digitize and Automate Medication Management Throughout its Health System Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare...
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Thursday, October 24, 2019, to discuss the Company’s Third Quarter 2019 financial results. About Omnicell ...
Leading Health System to Leverage Automation for Enhanced Efficiency and Safety in Central Pharmacy Operations and Clinical Care Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced...
Implementation of automated dispensing cabinets and interoperability with electronic health record streamlines workflow, supports medication safety Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharma...
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 15, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a fede...
Class-action law firm urges OMCL investors to learn their shareholder rights against Omnicell SAN FRANCISCO, CA / ACCESSWIRE / September 14, 2019 / Hagens Berman reminds investors in Omnicell, Inc. (NASDAQ:OMCL) of the September 16, 2019 deadline to move for lead plaintiff in a fede...
News, Short Squeeze, Breakout and More Instantly...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT. Live and archived webcasts of the presentation will be available through the Om...
2024-05-03 08:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Results exceed prior first quarter guidance across all metrics Total GAAP revenues of $246 million Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a ...